Syn2bio Spolka Akcyjna (S2B)
GPW
62.20
+1.89 (+3.13%)
Closed
Aug 21, 2026
Day's Range
60.0162.44
52 wk Range
26.2096.60
Financial Statements - S2B - Syn2bio Spolka Akcyjna
Revenue
0
Net Income
-23.66M▼ 44.8%
EBITDA
-28.32M▼ 44.6%
Free Cash Flow
-21.08M▲ 6.4%
Income Statement
| Period Ending | 2025-09-30 | 2024-09-30 | 2023-09-30 |
|---|---|---|---|
| Sales | 0 | 0 | 0 |
| Cost of Goods | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 |
 Operating Expense | - | - | - |
| Operating Income | -28.93M | -19.88M | -13.99M |
| Non-Operating Interest | - | - | - |
| Other Income Expense | - | - | - |
| Pre Tax Income | -28.97M | -19.93M | -14.04M |
| Income Tax | -5.31M | -3.58M | -2.20M |
| Net Income | -23.66M | -16.34M | -11.84M |
| EPS Basic | - | -1.872277 | -1.357267 |
| EPS Diluted | - | -1.872277 | -1.357267 |
| Basic Shares Outstanding | - | 8.72M | 8.72M |
| Diluted Shares Outstanding | - | 8.72M | 8.72M |
| Ebit | -28.92M | -19.88M | -13.99M |
| Ebitda | -28.32M | -19.58M | -13.50M |
| Net Income Continuous Operations | -28.97M | -19.93M | -14.04M |
| Minority Interests | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
